Rankings
▼
Calendar
EVAX Q3 2020 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena
EVAX
Evaxion Biotech A/S
$23M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$4M
EPS (Diluted)
$-9.92
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$11M
Total Liabilities
$3M
Stockholders' Equity
$8M
Cash & Equivalents
$8M
← FY 2020
All Quarters
Q4 2020 →